Business Context and Reporting Period
Company: Spatializer Audio Laboratories, Inc. (Note: Input metadata referenced "Enveric Biosciences," but the filing text identifies the registrant as Spatializer Audio Laboratories, Inc.)
Period: Fiscal year ended December 31, 2010
Status: Shell Company / Going Concern Doubt
Spatializer Audio Laboratories, Inc. sold substantially all of its intellectual property assets to DTS, Inc. in July 2007. Since the third quarter of 2007, the Company has had no source of revenue and no full-time employees. The Company currently operates as a shell corporation with the stated policy of maintaining reporting status to facilitate a potential merger or sale. The financial statements include an auditor's emphasis of matter regarding substantial doubt about the Company's ability to continue as a going concern.
Key Financial Metrics
| Metric | 2010 | 2009 |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Expenses | $35,875 | $55,569 |
| Net Loss | $(39,441) | $(58,544) |
| Cash and Cash Equivalents (End of Period) | $1,126 | $1,792 |
| Working Capital | $(49,516) | $(10,075) |
| Total Liabilities | $50,642 | $11,867 |
| Stockholders' Equity (Deficit) | $(49,516) | $(10,075) |
Liquidity: The Company relies entirely on advances from shareholder/officers to fund operations. As of December 31, 2010, $40,000 was advanced and recorded as "Loans from Shareholders." An additional $13,000 was advanced in January 2011.
Material Changes vs. Prior Period
- Expense Reduction: Operating expenses decreased by approximately 35% (from $55,569 in 2009 to $35,875 in 2010), primarily due to reduced general and administrative costs.
- Net Loss Improvement: Net loss narrowed from $58,544 in 2009 to $39,441 in 2010.
- Liability Increase: Total current liabilities increased significantly from $11,867 to $50,642, driven by the $40,000 in shareholder loans and accrued professional fees of $8,000.
- Working Capital Deterioration: Negative working capital worsened from $(10,075) to $(49,516) due to the increase in liabilities outpacing the minimal cash balance.
- Stock Options: All outstanding stock options expired or were forfeited during 2010, leaving zero options outstanding as of year-end.
Outlook, Risks, and Management Commentary
Outlook: Management states there is no current business model or revenue source. The Company's strategy is to retain earnings (if any) to maintain reporting status and potentially sell the Company as a shell or merge with a new operating business. Future operations depend entirely on outside funding.
Risks and Contingencies:
- Going Concern: Substantial doubt exists regarding the Company's ability to continue operations without new funding or a business model change.
- Liquidity: Cash balance is critically low ($1,126). Continued operations depend on shareholder advances.
- Stock Liquidity: The stock trades on the OTC Bulletin Board with low volume and high volatility. There is no assurance market makers will continue to quote the stock.
- Dilution: Any future financing to pursue business opportunities will likely dilute existing stockholders.
- Tax Assets: The Company has net operating loss carryforwards of approximately $9.5 million, but a full valuation allowance has been established due to the uncertainty of future taxable income.
Investor Verification Checklist
- Going Concern Status: Verify if the Company has secured a new business plan, merger partner, or significant capital injection since the filing date (March 3, 2011).
- Shareholder Loans: Confirm the terms and repayment status of the $40,000+ in loans from officers/shareholders.
- Stock Liquidity: Check current OTC trading volume and bid-ask spreads to assess the ability to exit the position.
- Regulatory Compliance: Verify the Company remains current on all SEC filings to avoid delisting from the OTC Bulletin Board.
- Management Intent: Review recent press releases or 8-K filings for any announcements regarding a reverse merger or acquisition.